Swiss National Bank Taro Pharmaceutical Industries LTD Transaction History

Swiss National Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$32.77 - $42.31 $75,371 - $97,313	-2,300 Reduced 11.0%	18,600 $777,000
Q2 2023 Aug 09, 2023	BUY	$24.24 - $40.97 $9,696 - $16,388	400 Added 1.95%	20,900 $792,000
Q1 2023 May 10, 2023	SELL	$23.0 - $31.59 $46,000 - $63,180	-2,000 Reduced 8.89%	20,500 $498,000
Q2 2022 Aug 09, 2022	BUY	$35.0 - $43.59 $7,000 - $8,718	200 Added 0.9%	22,500 $814,000
Q1 2022 May 09, 2022	BUY	$43.12 - $50.3 $60,368 - $70,420	1,400 Added 6.7%	22,300 $965,000
Q4 2021 Feb 08, 2022	SELL	$47.6 - $65.0 $14,280 - $19,500	-300 Reduced 1.42%	20,900 $1.05 Million
Q2 2021 Aug 06, 2021	SELL	$70.26 - $76.64 $42,156 - $45,984	-600 Reduced 2.75%	21,200 $1.53 Million
Q4 2020 Feb 05, 2021	BUY	$54.4 - $73.42 $1.19 Million - $1.6 Million	21,800 New	21,800 $1.6 Million
Q4 2017 Feb 07, 2018	SELL	$104.5 - $126.38 $4.92 Million - $5.95 Million	-47,100 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$97.26 - $116.2 $4.58 Million - $5.47 Million	47,100	47,100 $5.31 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.